Fagan Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,597
| Closed | -$233K | – | 133 |
|
|
2025
Q1 | $233K | Buy |
2,597
+200
| +8% | +$18K | 0.04% | 115 |
|
|
2024
Q4 | $238K | Hold |
2,397
| – | – | 0.04% | 123 |
|
|
2024
Q3 | $272K | Sell |
2,397
-98
| -4% | -$11.1K | 0.05% | 117 |
|
|
2024
Q2 | $309K | Hold |
2,495
| – | – | 0.05% | 105 |
|
|
2024
Q1 | $329K | Buy |
2,495
+100
| +4% | +$13.2K | 0.06% | 105 |
|
|
2023
Q4 | $261K | Sell |
2,395
-100
| -4% | -$10.9K | 0.06% | 103 |
|
|
2023
Q3 | $257K | Buy |
2,495
+75
| +3% | +$7.72K | 0.06% | 103 |
|
|
2023
Q2 | $279K | Buy |
2,420
+68
| +3% | +$7.85K | 0.07% | 100 |
|
|
2023
Q1 | $250K | Hold |
2,352
| – | – | 0.06% | 112 |
|
|
2022
Q4 | $261K | Hold |
2,352
| – | – | 0.07% | 109 |
|
|
2022
Q3 | $203K | Hold |
2,352
| – | – | 0.06% | 116 |
|
|
2022
Q2 | $214K | Buy |
+2,352
| New | +$214K | 0.06% | 115 |
|